US Stock MarketDetailed Quotes

IOBT IO Biotech

Watchlist
  • 0.931
  • -0.009-0.95%
Close Feb 14 16:00 ET
  • 0.931
  • 0.0000.00%
Post 20:01 ET
61.34MMarket Cap-0.72P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Feb 4 07:09
    NEWS
    $IO Biotech (IOBT.US)$
    IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate
    Tuesday, 4th February at 8:05 am
    – Submission of Investigational New Drug Application (IND) to US FDA expected in 2025 –
    NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- IO Biotech (NASDAQ: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vacci...
    Trytosaveabit
    Trytosaveabit
    Jan 9 13:06
    Update Thursday 1/9/25
    $IO Biotech (IOBT.US)$ Reuters· 08:051min
    IO Biotech Completes Enrollment in Phase 2 Trial of Its Investigational, off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients With Resectable Melanoma or Head and Neck Cancer
    Jaguar8
    Jaguar8
    Jan 9 08:06
    NEWS
    $IO Biotech (IOBT.US)$
    IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer
    Thursday, 9th January at 8:05 am
    -- Enrollment Completed Ahead of Schedule --
    -- Initial Data Expected in 2025 --
    NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- IO Biotech (NASDAQ: IOBT), a clinical-stage biopharmaceutical company developing novel, ...
    Trytosaveabit
    Trytosaveabit
    Dec 20, 2024 07:09
    News
    $IO Biotech (IOBT.US)$ Reuters· 3 mins ago
    IO Biotech Secures up to €57.5 Million in Debt Financing From the European Investment Bank
    Jaguar8
    Jaguar8
    Nov 7, 2024 09:02
    NEWS
    $IO Biotech (IOBT.US)$
    IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study
    IO Biotech announced promising Phase 2 results for its cancer vaccine IO102-IO103 combined with KEYTRUDA® in first-line metastatic lung cancer treatment. The study showed a 55% unconfirmed/48% confirmed overall response rate and 8...
Read more
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Alibaba
BABA
+4.34%
Micron Technology
MU
+4.04%
NVIDIA
NVDA
+2.63%
Cisco
CSCO
+1.61%
Netflix
NFLX
+1.43%

Unlock the Full List